Objective: The present study was aimed at developing a new cell-permeant peptide inhibitor (MK2i) of the kinase that phosphorylates and activates heat-shock protein (HSP)27 (MAPKAP kinase II), and evaluating the ability of this peptide to inhibit HSP27 phosphorylation and intimal thickening. Methods: The ability of MK2i to reduce HSP27 phosphorylation and cell migration was evaluated in A7R5 cells stimulated with arsenite or lysophosphatidic acid. Stable isotopic labeling using amino acids in cell culture, in combination with liquid chromatography mass spectrometry, was used to characterize the effect of MK2i on global protein expression in fibroblasts. The effect of MK2i on intimal thickening and connective tissue growth factor expression was evaluated in human saphenous vein (HSV) rings maintained with 30% fetal bovine serum for 14 days by light microscopy and immunoblotting. Intimal hyperplasia represents the leading cause of prosthetic and autologous vascular graft failure.
Intimal hyperplasia represents the leading cause of prosthetic and autologous vascular graft failure. 1 Despite the many recent technological advances in vascular interventions, intimal hyperplasia remains an expensive, morbid, and unsolved problem. 2 While incompletely understood, intimal hyperplasia involves a response to injury and is mediated by a sequence of events that include smooth muscle cell proliferation, migration, phenotypic modulation, and extracellular matrix deposition. 3 Heat-shock protein (HSP)27 (also termed HSPB1, HSP25) is a member of the family of small heat-shock proteins. The expression and phosphorylation of HSP27 increase with stress. Increases in the phosphorylation of HSP27 are associated with enhanced cell migration 4, 5 and with abundant stress fiber formation, 6, 7 effects attributed to HSP27 stabilization of the actin cytoskeleton. In addition to cell migration, stabilization of the cytoskeleton is also associated with the expression of extracellular matrix proteins, [8] [9] [10] another key event related to intimal hyperplasia. Therefore, because HSP27 expression and phosphory- lation largely influence the cytoskeleton and, consequently, events associated with intimal hyperplasia, modulation of its phosphorylation may be a target to prevent intimal hyperplasia.
The goal of the present study was to develop a cellpermeant peptide inhibitor (named MK2i) of the kinase that phosphorylates and activates HSP27 and to evaluate its potential as a new strategy to prevent intimal hyperplasia. HSP27 is phosphorylated by a kinase cascade that involves p38 MAP kinase, which phosphorylates and activates MAPKAP kinase II, which, in turn, phosphorylates HSP27. To date, HSP27 is the only heat-shock protein known to be phosphorylated by MAPKAP kinase II. 11 While small molecule inhibitors of p38 MAP kinase have been developed, toxicity has limited the clinical use of these inhibitors. 4 We developed MK2i using a protein transduction domain and a modification of a peptide designed by Hayess and Benndorf that binds to and inhibits the catalytic site of MAPKAP kinase II. 12 Protein transduction domains (PTDs) were used because of their ability to carry other peptides, proteins, and even small particles across cell membranes. 13 In this study, we evaluated the effect of MK2i on the phosphorylation of HSP27, cell migration, global protein expression, and intimal thickening. Our results demonstrate the potential of MK2i to prevent intimal hyperplasia.
MATERIAL AND METHODS
Materials. MK2i (WLRRIKAWLRRIKALNRQLGVAA) was synthesized and purified using standard FMOC (9-fluorenylmethyloxycarbonyl) chemistry and high-pressure liquid chromatography. All chemicals were purchased from Sigma Chemical Co (St Louis, MO) unless specified otherwise.
Cell culture. A7R5 cells (embryonic rat aortic smooth muscle cells) were purchased from ATCC (Manassas, Va) and were grown at 37°C and 5% CO 2 in Dulbecco's modification of Eagle's medium (DMEM) containing 10% fetal bovine serum, penicillin, and streptomycin (1%), in 60-mm 2 dishes. When the cells reached 70% confluence, they were growth-arrested by using a medium containing 1% bovine serum albumin for 24 hours prior to each experiment. A7R5 cells were chosen because this is a well-characterized smooth muscle cell line, often used in cell migration assays, and sensitive to transforming growth factor (TGF) and lysophosphatidic acid (LPA) stimulations, mediators related to the development of intimal hyperplasia.
14 Cell treatment. On the day of each experiment, fresh media (containing 1% bovine serum albumin) was added to the dishes, and cells were either untreated (control) or pre-treated with MK2i (5, 10, or 20 M) or with 20 M SB203580 (SB, a p38 MAP kinase inhibitor; Cal Biochem, San Diego, Calif) for 2 hours. For comparison, cells were also treated with the commercial peptide inhibitor of HSP27 phosphorylation that is not cell permeant (BN, 10 M). 12 The cells were then stimulated with LPA (25 M) for 1 hour or sodium arsenite (ARS; 500 M) for 0.5 hours as described earlier. 18 Stimulation with LPA or ARS has been demonstrated to increase the phosphorylation of HSP27. 15, 16 At the end of the experiments, cells were rinsed with phosphate buffered saline (PBS), quick-frozen, and protein-extracted using urea-DTT-CHAPS buffer (8 M urea, 10 
Cell migration. Migration was studied using a scratch-wound motility assay. The scratch-wound assay has been used for nearly half a century as an in vitro model of wound healing and as a tool to discover factors important for cell migration. 17 For this assay, A7R5 cells were cultured in a six-well dish and allowed to reach confluence; a linear scratch (ϳ2 mm wide) was performed with a 10-L pipette tip across the diameter of the well and rinsed with PBS. Cells were kept in serum-free medium for 24 hours, pretreated with MK2i at 10 M for 2 hours, and stimulated with LPA, which stimulates migration of smooth muscle cells.
14 Pictures were taken on a Zeiss Axiovert 200 M epifluorescence microscope (Carl Zeiss Inc, Thornwood, NY), at a magnification of 20 and 40 X at 0 and 48 hours, and the number of cells that invaded the scratch was determined.
Stable isotopic labeling of cells in culture. To determine the effect of MK2i on global protein expression, model system human dermal keloid fibroblasts were used. The choice of keloid fibroblasts was based on the fact that TGF-␤ effects are better characterized in these cells compared with endothelial or smooth muscle cells. Since TGF-␤ is an important mediator of intimal hyperplasia (causing matrix production and deposition, smooth muscle ␣-actin expression and myofibroblast differentiation 18 ), we opted to use a cell model in which TGF-␤ effects are well described. Also, our earlier investigation had characterized the effect of MK2i peptide on the TGF-␤-induced phosphorylation of HSP27 and expression of connective tissue growth factor and collagen I in keloid fibroblasts, a woundhealing model. 19 In addition, keloid fibroblasts express robust stress fibers and ␣-smooth muscle actin, characteristics that confer some similarity to smooth muscle cells.
Fibroblasts were cultured in 60-mm dishes in the presence of one of the isotopic medias (with labeled aminoacid, arginine, lysine, or cysteine) containing 10% dialyzed fetal bovine serum (FBS). Cells cultured in these media for six passages achieved a 98.9% incorporation of isotopic amino acids (data not shown). The workflow of cell manipulation is shown in Fig 1. Cells potentiated in 0.5% dialyzed FBS for 48 hours prior to treatment were treated for 24 hours with 1) a control -untreated; 2) TGF-␤1 (1.25 ng/mL) or 3) TGF-␤1 (1.25 ng/mL) ϩ 10 M MK2i. After treatment, cells were washed in PBS then harvested by scraping in urea/DTT/CHAPS buffer. Protein extracts from each medium (25 g each) were combined 1:1:1 based on the Coomassie Plus protein assay. The pooled protein extracts were separated on 4% to 20% precast gradient sodium dodecyl sulfate-polyacrylamide gels and visualized with Coomassie blue. The resulting gel lane from each experiment was cut into 20 slices of approximately equal size. High-performance liquid chromatography-electrospray tandem mass spectrometry was performed on a linear ion trap mass spectrometer LTQ-Fourier Transform Ion Cyclotron Resonance mass spectrometer (LTQ FT; Thermo Fisher, San Jose, Calif) fitted with a PicoView nanospray source (New Objective, Woburn, Mass) as described. 20 The search parameters used for both RAW and DAT file searches were: 0.5 Da mass tolerance for precursor ion masses and 10 ppm for product ion masses; digestion with trypsin/p; a maximum of two missed tryptic cleavages; variable modifications of oxidation of methionine and phosphorylation of serine, threonine, and tyrosine, ϩ6 on lysine (13C 6 label), ϩ6 on arginine (13C 6 label), ϩ10 on arginine (U-13C , and ϩ57 on cysteine (carbamidomethylation). Probability assessment of peptide assignments and protein identifications within "DAT" files were made through use of Scaffold (version Scaffold-01_07_17; Proteome Software Inc, Portland, Ore). Only peptides with Ն95% probability as considered by the ProteinProphet algorithm were included in the final table. Criteria for protein identification included detection of at least two unique identified peptides and a probability score of Ն99%. Proteins were quantified using the MSQuant Suite of software (http://msquant. sourceforge.net/) as described.
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Construction of cell-permeant HSP27 fusion protein. The cDNA encoding human HSP27 was polymerase chain reaction amplified from an I.M.A.G.E (Integrated Analysis of Gene Expression). Clone (clone ID 6083486; Clontech, Palo Alto, Calif) using a forward primer (5'-GATCGAGCTCATGACCGAGCGC-CGCGTC-3') and a reverse mutagenic primer (5'-gatcggtaccttacttggcggcagtctcatcgg-3') then cloned into pCDNA3.1 (Invitrogen, Carlsbad, Calif), yielding pCDNA3.1-HSP27.
) encoding a PTD were annealed, phosphorylated, and ligated into NdeI-BamHI-digested pET14b Schematic of workflow used for a three-way SILAC-MS experiment. Three cell populations are isotopically labeled with normal and stable isotope-substituted arginine (R) and lysine (K) amino acids, creating three cell populations distinguishable by mass. Each population is stimulated as indicated yielding three samples that are combined in equal amounts (25 g each), trypsin-digested, and analyzed using mass spectrometry.
(Novagen, Madison, Wisc) producing pET14b-PTD. The cDNA encoding HSP27 was liberated from pCDNA3.1-HSP27 with SacI-XhoI digestion and ligated into SacI/ XhoI-digested pET14b-PTD yielding pET14b-PTD-HSP27. Base sequences for all DNAs were confirmed by nucleotide sequence analysis, and protein was expressed in Escherichia coli. Briefly, single colonies of BL21 (DE3; Novagen) containing recombinant pET14b-PTD-HSP27 were used to inoculate 3 liters of Luria Broth (LB) containing 50 mg/L of ampicillin. Cultures were induced with 2 mM isopropyl-1-thio-␤-D-galactopyranoside when the optical density at 600-nm wavelength reached 0.6-1. After 5 hours, cells were harvested by centrifugation (6,000 g, 10 minutes), resuspended in 1ϫ TNE buffer (50 mM NaCl, 1 mM ethylenediaminetetraacetic acid [EDTA] , and 500 mM Tris, pH 8.0), and sonicated on ice. After sonication, the inclusion bodies were harvested by centrifugation (19,000 g, 10 minutes) and resuspended in binding buffer (20 mM Na 2 HPO 4 , 0.5 M NaCl, 50 mM imidazole, pH 7.4, and 8 M urea). The sample was then added to Ni 2ϩ -charged Chelating Sepharose Fast Flow (Pharmacia Biotech, Peapack, NJ) and incubated overnight at 4°C. The resin was then loaded into a Poly-Prep column (Bio-Rad, Richmond, Calif), and protein was eluted with 2 mL of 500 Muscle physiology. De-identified discarded segments of human saphenous vein (HSV) were collected after the approval of the Institutional Review Board of the Arizona Heart Institute (Phoenix, Ariz) from consented patients undergoing coronary artery bypass or peripheral vascular bypass surgery. To test the viability, rings (1.0 mm in width) were cut from segments of saphenous vein, dissected free of fat and connective tissue, stripped of the endothelium (to focus on smooth muscle responses), and contracted as described earlier. 32 To test the effect of MK2i on the relaxation of HSV, rings were washed in bicarbonate buffer and incubated with either buffer (control), 25 M SB, or 30 M MK2i for 2 hours. Rings were contracted with norepinephrine (0.5 M) and relaxed with cumulative log doses of sodium nitroprusside (0.01-1 M), a nitric oxide donor.
Organ culture. After viability was determined in the muscle bath, additional rings (3 mm in length) were cut, placed in eight-well chamber slides, and maintained in RPMI 1640 medium with 30% FBS, 1% L-glutamine, and 1% penicillin/streptomycin for 14 days at 37°C/5% CO 2 as described. 32 The rings were either untreated, or treated with MK2i (5 or 10 M), SB (25 M), or recombinant HSP27 protein attached to a protein transduction domain for cell penetration (19 M) . The experiments were conducted in duplicate for every vein segment: one set of rings was used for histological evaluation, while the other set was used for evaluation of HSP27 phosphorylation and connective tissue growth factor (CTGF) expression by Western blot. To study the effect of MK2i on collagen accumulation in cultured vein rings, control rings and those treated with MK2i at 10 M were also stained for collagen using the Masson's trichrome stain.
The second set of rings was snap-frozen with liquid nitrogen, pulverized, and homogenized using Urea-DTT-CHAPS buffer. Lysates were centrifuged (6000 g, 20 minutes), and the supernatant was collected for subsequent evaluation of HSP27 phosphorylation and CTGF expression.
Immunoblot analysis. Protein from cells or HSV ring lysates were electrophoretically separated, transferred to Immobilon membranes, and analyzed by Western blotting as described earlier 10 with the following primary antibodies: rabbit anti-CTGF (Torrey Pines Biolabs, Houston, Tex), mouse anti-HSP27 (gift from Dr Michael Welsh, University of Michigan), rabbit anti-phosphorylated HSP27, 22 and rabbit anti-␤-actin (Sigma, St. Louis, Mo). Statistical analysis. All protein expression data are presented as means Ϯ standard deviation. The Western blot bands were quantified by densitometry, and proteins expression normalized from the amount of the loading control (␤-actin) expression. One-way analysis of variance followed by Tukey test was used to compare experimental groups, with a significance level of P Ͻ .05.
RESULTS
The effect of MK2i on HSP27 phosphorylation in A7R5 cells. Treatment with ARS (0.5 mM) or LPA (25 M) increased the phosphorylation of HSP27 in A7R5 cells (Fig 2) . Pretreatment with 10 M MK2i decreased ARS and LPA-induced HSP27 phosphorylation by 36% Ϯ 9% and 33% Ϯ 10%, respectively (P Ͻ .05; Fig 2) . Since rat aortic smooth muscle cells undergo changes in culture from the contractile to a synthetic phenotype, the level of PKG (cGMP-dependent protein kinase, a phenotypic marker of smooth muscle cells) was monitored, and experiments were conducted only in cells expressing PKG (data not shown). Several investigations have demonstrated that expression of cyclic GMP-dependent protein kinase results in the expression of smooth muscle specific myosin heavy chains, calponin, and ␣-smooth muscle actin, all markers considered to be associated with the contractile phenotype. 23, 24 As a control, cells were also treated with the p38 MAP kinase inhibitor SB. P38 MAP kinase acts upstream to MAPKAP kinase II, phosphorylating and activating it. SB pretreatment led to decreases in the phosphorylation of HSP27 after stimulation with either ARS or LPA (71% Ϯ 7% or 52% Ϯ 23%, respectively, compared with no SB, P Ͻ .05). Additionally, treatment with the peptide inhibitor of MAPKAP kinase II that does not contain a protein transduction domain (BN) did not lead to decreases in LPA-or ARS-induced increases in the phosphorylation of HSP27 (Fig 2, C) . This is likely due to the inability of this peptide to penetrate into cells. Effect of MK2i on cell migration. A scratch assay was performed to determine the effect of MK2i on smooth muscle cell migration stimulated by LPA.
14 MK2i (10 M) pretreatment decreased LPA-induced migration by 52% Ϯ 16% (P Ͻ .05) compared with cells stimulated with LPA but not pretreated with MK2i (Fig 3) .
Proteomic profiling of MK2i-mediated protein change. Stable isotopic labeling using amino acids in cell culture (SILAC) in combination with liquid chromatography (LC) mass spectrometry n (MS/MS) was used to characterize cellular responses in human dermal keloid fibroblasts upon stimulation with TGF-␤ that has demonstrated to induce HSP27 phosphorylation.
10 Fig 4 shows a typical MS/MS mass spectra of an arginine-containing peptide triplet (that is the same peptide derived from each of the three different media/treatments) and that of a lysinecontaining peptide triplet. The isotopic envelope of a ϩ2 charged peptide SLQEEHVAVAQLR, derived from the protein histone H2 in Media 1, has a monoisotopic protonated mass of 1485.81 (yellow dot), a ϩ6R amino acid from Media 2 (1479.79, red dot), and the ϩ10R labeled peptide from Media 3 (1489.80, blue dot). The envelope of each peptide reflects a typical distribution and is a consequence of naturally-abundant carbon, nitrogen, oxygen, and hydrogen atoms. The spacing of the monoisotopic mass peaks from each ϩ2 charged peptide envelope is indicated by the red arrows. The relative intensities of each monoisotopic mass peak are proportional to the abundance of that peptide in the media. Fig 4B shows a similar mass spectra for a lysine-containing ϩ3-charged peptide triplet derived from the protein plectin 1. The Table lists those proteins most upregulated upon TGF-␤ stimulation and those most downregulated upon TGF-␤ ϩ MK2i treatment. Of note, two extracellular matrix proteins implicated in hyperplastic lesions, fibronectin and collagen, were downregulated after MK2i treatment. MK2i not only decreased the phosphorylation of HSP27 but also decreased its expression.
Effect of MK2i on the phosphorylation of HSP27 and expression of CTGF in cultured HSV rings. We evaluated the effect of MK2i on the expression/phosphorylation of HSP27 and CTGF in cultured HSV rings used as an ex vivo model of intimal hyperplasia. MK2i (10 M) decreased the phosphorylation of HSP27 by 40% Ϯ 17% (P Ͻ .05; Fig 5, A and B) while SB decreased the phosphorylation of HSP27 by 58% Ϯ 22% (P Ͻ .05) compared with untreated controls.
CTGF has been proposed to mediate some of the pro-fibrotic effects of TGF-␤ (and other pro-fibrotic mediators) including production of extracellular matrix proteins. An intact cytoskeleton is required for CTGF expression. 8 Since HSP27 phosphorylation is associated with actin cytoskeleton stabilization, we hypothesized that reduction of HSP27 phosphorylation would reduce CTGF expression. The expression of CTGF was decreased by 17% Ϯ 5% with MK2i (10 M), and by 28% Ϯ 7% with SB, compared with untreated controls (P Ͻ .05; Fig 5, A and  C) . MK2i also decreased TGF-␤-induced CTGF expression in A7R5 cells (29% Ϯ 11%; data not shown).
Effect of MK2i on the development of intimal hyperplasia. Finally, we determined the effect of MK2i on intimal thickening in HSV. The average intimal thickness of the pre-cultured HSV was 15.8 Ϯ 3.4 m. After 14 days in culture, the average intimal thickness of the untreated (control) rings was 44.3 Ϯ 9.4 m, an increase of over 100% in the thickness of the intimal layer (Fig 6, A) . Treatment with MK2i (10 M) and SB significantly reduced the intimal thickness by 48.2% Ϯ 10.5% and 61.9% Ϯ 5.4%, respectively, compared with untreated controls (P Ͻ .05). To further support the hypothesis Human dermal keloid fibroblasts treated with TGF-␤ (1.25 ng/mL) and TGF-␤ ϩ MK2i (10 M) for 24 hours were analyzed using SILAC-labeling and MSQuant-mediated protein quantification.
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that HSP27 is involved in the development of intimal hyperplasia, we generated a fusion protein containing recombinant HSP27 attached to a protein transduction domain to allow cell penetration of the protein (r-HSP27). The rings treated with r-HSP27 (19 M) developed an increase of 48% Ϯ 14% (P Ͻ .05) in intimal thickening compared with control rings. The ratio intimal/media layer for each treatment is shown in Fig 6G. Again, a significant (P Ͻ .05) decrease in this ratio was observed when the rings were treated with MK2i (at 10 M) or SB compared with the untreated rings, whereas r-HSP27 increased this ratio.
Since deposition of extracellular matrix proteins is a key feature of intimal hyperplasia, we evaluated how MK2i treatment affected collagen deposition in the vein rings. Control rings and those treated with MK2i at 10 M were stained for collagen using the Masson's trichrome stain. As can be seen in Fig 7, deposition of collagen was observed in the neointima of untreated rings cultured for 14 days (Fig  7, A) . Treatment with MK2i reduced collagen accumulation (Fig 7, B) .
MK2i enhances relaxation of HSV. We examined the effect of inhibiting the phosphorylation of HSP27 on nitric oxide-induced relaxation of saphenous vein. HSV rings were contracted with norepinephrine (0.5 M) and relaxed with sodium nitroprusside (a nitric oxide donor 0.01-1 M), with or without preincubation with MK2i or SB and the force generated was recorded. Preincubation of HSV with 30 M MK2i increased sodium nitroprusside (0.1 M)-induced relaxation from 18.47% Ϯ 8% to 64.93% Ϯ 6.52% (Fig 8) , while SB (25 M) increased relaxation from 18.47% Ϯ 8% to 50.5% Ϯ 6.2%. MK2i did not affect the contraction of HSV significantly at the concentration used (data not shown).
DISCUSSION
The role of HSP27 in stabilizing the actin cytoskeleton (which leads to several key events associated with intimal hyperplasia) has been supported by several lines of evidence. Transfection of cells with dominant active phosphorylated mutants of HSP27 leads to abundant stress fiber formation. 6, 7 The presence of central actin stress fibers in cultured cells is associated with the "synthetic" or "myofibroblast" phenotype. 25 HSP27 has also been shown to be induced by stress, particularly in the vasculature. 22, 26 Increases in the phosphorylation of HSP27 are also associated with smooth muscle migration. 4 Migration of smooth muscle cells from the media to the hyperplastic lesion has been implicated as one of the inciting events in intimal hyperplasia. 27 The expression and phosphorylation of HSP27 doubles after exposure of human saphenous vein segments to arterial flow ex vivo. 28 Vein graft arterialization also leads to activation of p38 MAPK. 29 Hence, molecular strategies that inhibit HSP27 phosphorylation would prevent smooth muscle cell migration, phenotypic modulation to a myofibroblast, extracellular matrix production, and intimal hyperplasia.
In this study, we examined the effect of a cell-permeant peptide inhibitor (MK2i) of the kinase that phosphorylates and activates HSP27, and evaluated its potential to inhibit the phosphorylation of HSP27 and prevent intimal hyperplasia. We used HSV cultured in the presence of high serum as an ex vivo model of intimal hyperplasia, which has been reported as a representative ex vivo model of the changes following vein graft stenosis in man 30, 31 and had been used previously in our laboratory. 32 Accordingly, marked similarities were previously observed in the cellular and extracellular matrix composition in the intimal layer of the cultured vein and the pathological lesion, with both showing abundance of collagen and smooth muscle cells of secretory phenotype. 33 Using bromodeoxyuridine as a proliferation marker, it was observed that early cell proliferation in the cultured vein intima gave rise to the neointima. Both proliferation and neointimal thickness were maximal by day 14 in culture, hence justifying the culture of rings for 14 days. Cell proliferation and increases in the crosssectional area of the medial layer have also been observed in this model. The fact that the pre-treatment with MK2i decreased LPA-and ARS-induced phosphorylation of HSP27 in a smooth muscle cell line suggests the potential of this peptide to penetrate into cells and target MAPKAP kinase II. As expected, this effect was not observed when the peptide inhibitor of MAPKAP kinase II was not attached to a protein transduction domain (and therefore, not cell permeant), suggesting that the transduction domain is necessary for adequate cell penetration of the peptide.
During the course of the intimal hyperplasia, the tissue transitions from highly cellularized and proliferative to a neointima dominated by matrix components, with fibrosis becoming the prevailing event. 35 Recent studies have implicated TGF-␤1 and CTGF as canonical mediators of both phases of intimal hyperplasia since these growth factors are involved in matrix production and deposition, smooth muscle ␣-actin expression, and myofibroblast differentiation. 18 While an increased expression of TGF-␤1 was observed in hyperplastic tissue, TGF-␤1 antisense treatment reduced intimal hyperplasia and stenosis in animal models. 36 This and previous studies from our group demonstrate that TGF-␤1 treatment increases phosphorylation of HSP27 and production of connective tissue growth factor (CTGF) and collagen (Table) . 19 Since several of the TGFand CTGF-mediated effects are dependent on MAPKAP kinase II, 37 MK2i has the potential to counteract such effects. 19 As demonstrated by SILAC method, a tool that can determine the effect of agonists and drugs on global protein expression, 21 TGF-␤1 treatment increased the expression of two of the major extracellular matrix proteins found in intimal hyperplastic lesions: collagen I and fibronectin (Table) . MK2i treatment decreased the expression of both proteins. Interestingly, HSP27 expression was also regulated by MK2i. Recently, our group has evaluated the effect of MK2i on TGF-␤-induced phosphorylation of HSP27 in keloid cells and demonstrated that, compared with the TGF-␤ stimulation, MK2i (10 M) significantly diminished HSP27 phosphorylation to levels similar to that of the untreated control cells. 19 Therefore, MK2i seems to be involved in decreasing expression and phosphorylation of HSP27. Upregulation of HSP27 in the smooth muscle cells of saphenous vein was previously observed as a result of vein exposure to simulated venous or arterial flow, 28 further supporting a role for HSP27 in tissue remodeling and intimal hyperplasia.
Intimal injury is believed to be followed by release of inflammatory mediators (such as growth factors and cytokines) that induce phenotypic changes of vascular smooth muscle cells from the quiescent "contractile" state to the active "synthetic" state and their migration from the media to the intimal layer. Once in the intima, these cells proliferate (becoming the major cell type) and synthesize extracellular matrix proteins, the predominant component of intimal hyperplasia. 35 Collagen is the most abundant matrix protein, but hyaluronic acid and fibronectin are also present. 38 As can be seen in Fig 7, deposition of collagen can be found in the neointima of rings cultured for 14 days in high serum, whereas MK2i treatment prevented such accumulation.
Treatment of the rings with MK2i significantly decreased the thickness of intimal layer compared with untreated HSV, while the opposite was observed for rings treated with a recombinant fusion protein of HSP27 (r-HSP27). The reduction of intimal thickening was associated with decreases in HSP27 phosphorylation, CTGF expression, and collagen deposition. The fact that MK2i decreased HSP27 expression in cells, phosphorylation, and intimal thickening in cultured vein segments provides evidences for the involvement of HSP27 in the actin cytoskeleton reorganization and development of intimal hyperplasia. Because expression of CTGF is believed to depend on an intact actin cytoskeleton, agents that compromise this 
Fig 8.
The p38 MAP kinase inhibitor, SB 203580, and HSP27 kinase inhibitor, MK2i, enhances nitroprusside-induced relaxation in saphenous vein. Saphenous veins were cut into rings, suspended in a muscle bath, and equilibrated in Krebs Ringer bicarbonate buffer for 2 hours. The rings were contracted with KCl (110 mM), and force generated was measured to check for viability. The rings were then pretreated with buffer (control), 25M SB203580 (SB), or 30 M MK2i for 2 hours and then contracted with norepinephrine (NE, 0.5 M) and relaxed with increasing doses of sodium nitroprusside (SNP, 0-1M). SB or MK2i treatment led to significant increases in the relaxation of saphenous vein. *, P ϭ .0335, #, P ϭ .0108 at 0.1 M SNP compared with control, n ϭ 3. integrity most likely have an effect in modulating CTGF expression.
9,10,39 CTGF has been implicated as an important mediator of intimal hyperplasia due to its involvement in collagen production, smooth muscle ␣-actin expression, and myofibroblast differentiation. Further investigation on signaling cascades affected by MK2i and their link to HSP27 phosphorylation and CTGF expression are still necessary, but because increases in the phosphorylation of HSP27 are associated with stabilization of the actin cytoskeleton, it is reasonable to expect that by decreasing HSP27 phosphorylation, MK2i affects CTGF expression and, in turn, collagen deposition.
Taken together, these results demonstrate the potential of using cell-permeant peptide-based therapeutics to target MAPKAP kinase II and reduce HSP27 phosphorylation as a strategy to inhibit the development of intimal hyperplasia and enhance the patency of vein grafts. 
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